Status:
COMPLETED
Ophthalmic Solution in Diabetic Corneal Alteration
Lead Sponsor:
D&V FARMA srl
Collaborating Sponsors:
San Giovanni Addolorata Hospital
Conditions:
Dry Eye Disease (DED)
Eligibility:
All Genders
18+ years
Brief Summary
Data analyses and revision of the DED symptoms in diabetic subjects. A novel ophthalmic solution containing cross-linked ha (CX-HA) and Chondroitin sulphate (CS) has been made available on the market....
Eligibility Criteria
Inclusion
- Diabetic Subjects affected by dry eye disease
Exclusion
- know allergies to CX-HA
- know allergies to CS
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06573606
Start Date
September 1 2021
End Date
September 1 2022
Last Update
August 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Giovanni-Addolorata Hospital
Rome, Italy, 00184